FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT00325403
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
349
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Hypertension
Interventions
DRUG:
Oral treprostinil (UT-15C) Sustained Release Tablets
OTHER:
Placebo
Sponsor
United Therapeutics